{
  "run_id": "a0327b002dec",
  "adapter": "null",
  "dataset_version": "0.1.0",
  "budget_preset": "constrained-8k",
  "metrics": [
    {
      "name": "action_quality",
      "tier": 3,
      "value": 0.0,
      "details": {
        "action_recommendation_count": 1,
        "method": "pairwise"
      }
    },
    {
      "name": "answer_quality",
      "tier": 2,
      "value": 0.1423611111111111,
      "details": {
        "per_question": [
          {
            "question_id": "cs03_q04_action",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "the hepatic enzyme pattern is consistent with a drug-drug interaction mediated through shared hepatic metabolism pathways, not direct hepatotoxicity",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "musculoskeletal safety endpoints track within expected ranges, confirming the safety signal is organ-specific to the liver",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q01_longitudinal",
            "win_rate": 0.2,
            "fact_details": [
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "tie",
                "verdict_raw": "TIE",
                "candidate_position": "A",
                "fact_score": 0.5
              },
              {
                "fact": "ALT elevations appeared progressively over multiple weeks of statin co-administration with onset timing correlating with cumulative exposure duration rather than a single acute event",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "the adverse signal is hepatic (ALT/AST elevation), not renal \u2014 kidney function markers remain stable while liver enzymes diverge",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "musculoskeletal safety endpoints track within expected ranges, confirming the safety signal is organ-specific to the liver",
                "winner": "tie",
                "verdict_raw": "TIE",
                "candidate_position": "B",
                "fact_score": 0.5
              }
            ]
          },
          {
            "question_id": "cs03_q13_paraphrase",
            "win_rate": 0.3,
            "fact_details": [
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "tie",
                "verdict_raw": "TIE",
                "candidate_position": "A",
                "fact_score": 0.5
              },
              {
                "fact": "ALT elevations appeared progressively over multiple weeks of statin co-administration with onset timing correlating with cumulative exposure duration rather than a single acute event",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "the ALT elevation pattern correlates with statin co-administration timing, not with immune activation or antibody response patterns",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "musculoskeletal safety endpoints track within expected ranges, confirming the safety signal is organ-specific to the liver",
                "winner": "candidate",
                "verdict_raw": "B",
                "candidate_position": "B",
                "fact_score": 1.0
              }
            ]
          },
          {
            "question_id": "cs03_q05_negative",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "the adverse signal is hepatic (ALT/AST elevation), not renal \u2014 kidney function markers remain stable while liver enzymes diverge",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q18_temporal",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "ALT elevations appeared progressively over multiple weeks of statin co-administration with onset timing correlating with cumulative exposure duration rather than a single acute event",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q19_distractor",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "the adverse signal is hepatic (ALT/AST elevation), not renal \u2014 kidney function markers remain stable while liver enzymes diverge",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q24_evidence",
            "win_rate": 0.1875,
            "fact_details": [
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "tie",
                "verdict_raw": "TIE",
                "candidate_position": "A",
                "fact_score": 0.5
              },
              {
                "fact": "the hepatic enzyme pattern is consistent with a drug-drug interaction mediated through shared hepatic metabolism pathways, not direct hepatotoxicity",
                "winner": "tie",
                "verdict_raw": "TIE",
                "candidate_position": "A",
                "fact_score": 0.5
              },
              {
                "fact": "Site 07 lab equipment issue is not the cause of ALT elevations",
                "winner": "tie",
                "verdict_raw": "TIE",
                "candidate_position": "A",
                "fact_score": 0.5
              },
              {
                "fact": "the ALT elevation pattern correlates with statin co-administration timing, not with immune activation or antibody response patterns",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "musculoskeletal safety endpoints track within expected ranges, confirming the safety signal is organ-specific to the liver",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "ALT elevations appeared progressively over multiple weeks of statin co-administration with onset timing correlating with cumulative exposure duration rather than a single acute event",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "the adverse signal is hepatic (ALT/AST elevation), not renal \u2014 kidney function markers remain stable while liver enzymes diverge",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q11_longitudinal",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "the hepatic enzyme pattern is consistent with a drug-drug interaction mediated through shared hepatic metabolism pathways, not direct hepatotoxicity",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "Site 07 lab equipment issue is not the cause of ALT elevations",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "the ALT elevation pattern correlates with statin co-administration timing, not with immune activation or antibody response patterns",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "musculoskeletal safety endpoints track within expected ranges, confirming the safety signal is organ-specific to the liver",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "ALT elevations appeared progressively over multiple weeks of statin co-administration with onset timing correlating with cumulative exposure duration rather than a single acute event",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "the adverse signal is hepatic (ALT/AST elevation), not renal \u2014 kidney function markers remain stable while liver enzymes diverge",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q12_severity",
            "win_rate": 0.5,
            "fact_details": [
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "candidate",
                "verdict_raw": "B",
                "candidate_position": "B",
                "fact_score": 1.0
              },
              {
                "fact": "the hepatic enzyme pattern is consistent with a drug-drug interaction mediated through shared hepatic metabolism pathways, not direct hepatotoxicity",
                "winner": "candidate",
                "verdict_raw": "A",
                "candidate_position": "A",
                "fact_score": 1.0
              },
              {
                "fact": "the adverse signal is hepatic (ALT/AST elevation), not renal \u2014 kidney function markers remain stable while liver enzymes diverge",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "the ALT elevation pattern correlates with statin co-administration timing, not with immune activation or antibody response patterns",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "musculoskeletal safety endpoints track within expected ranges, confirming the safety signal is organ-specific to the liver",
                "winner": "candidate",
                "verdict_raw": "B",
                "candidate_position": "B",
                "fact_score": 1.0
              },
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "candidate",
                "verdict_raw": "B",
                "candidate_position": "B",
                "fact_score": 1.0
              },
              {
                "fact": "Site 07 lab equipment issue is not the cause of ALT elevations",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "ALT elevations appeared progressively over multiple weeks of statin co-administration with onset timing correlating with cumulative exposure duration rather than a single acute event",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q15_negative",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "the ALT elevation pattern correlates with statin co-administration timing, not with immune activation or antibody response patterns",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "the hepatic enzyme pattern is consistent with a drug-drug interaction mediated through shared hepatic metabolism pathways, not direct hepatotoxicity",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q17_temporal",
            "win_rate": 0.0625,
            "fact_details": [
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "the hepatic enzyme pattern is consistent with a drug-drug interaction mediated through shared hepatic metabolism pathways, not direct hepatotoxicity",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "ALT elevations appeared progressively over multiple weeks of statin co-administration with onset timing correlating with cumulative exposure duration rather than a single acute event",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "the adverse signal is hepatic (ALT/AST elevation), not renal \u2014 kidney function markers remain stable while liver enzymes diverge",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "musculoskeletal safety endpoints track within expected ranges, confirming the safety signal is organ-specific to the liver",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "tie",
                "verdict_raw": "TIE",
                "candidate_position": "B",
                "fact_score": 0.5
              },
              {
                "fact": "Site 07 lab equipment issue is not the cause of ALT elevations",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "the ALT elevation pattern correlates with statin co-administration timing, not with immune activation or antibody response patterns",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q21_distractor",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "musculoskeletal safety endpoints track within expected ranges, confirming the safety signal is organ-specific to the liver",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q22_counterfactual",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "the hepatic enzyme pattern is consistent with a drug-drug interaction mediated through shared hepatic metabolism pathways, not direct hepatotoxicity",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "ALT elevations appeared progressively over multiple weeks of statin co-administration with onset timing correlating with cumulative exposure duration rather than a single acute event",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "the adverse signal is hepatic (ALT/AST elevation), not renal \u2014 kidney function markers remain stable while liver enzymes diverge",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "the ALT elevation pattern correlates with statin co-administration timing, not with immune activation or antibody response patterns",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "Site 07 lab equipment issue is not the cause of ALT elevations",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "musculoskeletal safety endpoints track within expected ranges, confirming the safety signal is organ-specific to the liver",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q03_longitudinal",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "the hepatic enzyme pattern is consistent with a drug-drug interaction mediated through shared hepatic metabolism pathways, not direct hepatotoxicity",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "Site 07 lab equipment issue is not the cause of ALT elevations",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "the adverse signal is hepatic (ALT/AST elevation), not renal \u2014 kidney function markers remain stable while liver enzymes diverge",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q06_paraphrase",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "the hepatic enzyme pattern is consistent with a drug-drug interaction mediated through shared hepatic metabolism pathways, not direct hepatotoxicity",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "Site 07 lab equipment issue is not the cause of ALT elevations",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q07_temporal",
            "win_rate": 0.16666666666666666,
            "fact_details": [
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "tie",
                "verdict_raw": "TIE",
                "candidate_position": "A",
                "fact_score": 0.5
              },
              {
                "fact": "ALT elevations appeared progressively over multiple weeks of statin co-administration with onset timing correlating with cumulative exposure duration rather than a single acute event",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q08_counterfactual",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "Site 07 lab equipment issue is not the cause of ALT elevations",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "ALT elevations appeared progressively over multiple weeks of statin co-administration with onset timing correlating with cumulative exposure duration rather than a single acute event",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q14_paraphrase",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "the hepatic enzyme pattern is consistent with a drug-drug interaction mediated through shared hepatic metabolism pathways, not direct hepatotoxicity",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "Site 07 lab equipment issue is not the cause of ALT elevations",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q16_negative",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "musculoskeletal safety endpoints track within expected ranges, confirming the safety signal is organ-specific to the liver",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q20_distractor",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "the ALT elevation pattern correlates with statin co-administration timing, not with immune activation or antibody response patterns",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "the hepatic enzyme pattern is consistent with a drug-drug interaction mediated through shared hepatic metabolism pathways, not direct hepatotoxicity",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          }
        ],
        "method": "pairwise"
      }
    },
    {
      "name": "budget_compliance",
      "tier": 1,
      "value": 0.16666666666666663,
      "details": {
        "total_questions": 24,
        "total_violations": 20,
        "violation_rate": 0.8333333333333334,
        "total_tokens": 125338,
        "avg_tokens_per_question": 5222.416666666667,
        "max_tokens_single_question": 5777,
        "total_wall_time_minutes": 0.92,
        "avg_wall_time_ms": 2311.5,
        "max_wall_time_ms": 5720.1,
        "per_question_timing": [
          {
            "question_id": "cs03_q19_distractor",
            "question_type": "distractor_resistance",
            "checkpoint": 58,
            "wall_time_ms": 5720.1,
            "total_tokens": 5709,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q18_temporal",
            "question_type": "temporal",
            "checkpoint": 58,
            "wall_time_ms": 4991.3,
            "total_tokens": 5490,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q24_evidence",
            "question_type": "evidence_sufficiency",
            "checkpoint": 58,
            "wall_time_ms": 3297.6,
            "total_tokens": 3082,
            "tool_calls": 4
          },
          {
            "question_id": "cs03_q13_paraphrase",
            "question_type": "paraphrase",
            "checkpoint": 46,
            "wall_time_ms": 2714.4,
            "total_tokens": 5462,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q21_distractor",
            "question_type": "distractor_resistance",
            "checkpoint": 79,
            "wall_time_ms": 2442.3,
            "total_tokens": 5631,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q08_counterfactual",
            "question_type": "counterfactual",
            "checkpoint": 99,
            "wall_time_ms": 2390.4,
            "total_tokens": 5701,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q22_counterfactual",
            "question_type": "counterfactual",
            "checkpoint": 79,
            "wall_time_ms": 2321.8,
            "total_tokens": 5656,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q03_longitudinal",
            "question_type": "longitudinal",
            "checkpoint": 99,
            "wall_time_ms": 2314.1,
            "total_tokens": 5774,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q02_null",
            "question_type": "null_hypothesis",
            "checkpoint": 46,
            "wall_time_ms": 2112.3,
            "total_tokens": 5271,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q15_negative",
            "question_type": "negative",
            "checkpoint": 79,
            "wall_time_ms": 2081.5,
            "total_tokens": 5767,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q09_longitudinal",
            "question_type": "longitudinal",
            "checkpoint": 18,
            "wall_time_ms": 2066.0,
            "total_tokens": 5413,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q06_paraphrase",
            "question_type": "paraphrase",
            "checkpoint": 99,
            "wall_time_ms": 2015.3,
            "total_tokens": 5340,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q12_severity",
            "question_type": "severity_assessment",
            "checkpoint": 79,
            "wall_time_ms": 2007.9,
            "total_tokens": 5709,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q11_longitudinal",
            "question_type": "longitudinal",
            "checkpoint": 79,
            "wall_time_ms": 1967.4,
            "total_tokens": 5602,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q17_temporal",
            "question_type": "temporal",
            "checkpoint": 79,
            "wall_time_ms": 1939.3,
            "total_tokens": 5599,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q01_longitudinal",
            "question_type": "longitudinal",
            "checkpoint": 46,
            "wall_time_ms": 1885.9,
            "total_tokens": 5554,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q14_paraphrase",
            "question_type": "paraphrase",
            "checkpoint": 99,
            "wall_time_ms": 1856.1,
            "total_tokens": 5587,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q10_evidence",
            "question_type": "evidence_sufficiency",
            "checkpoint": 18,
            "wall_time_ms": 1854.4,
            "total_tokens": 3221,
            "tool_calls": 4
          },
          {
            "question_id": "cs03_q16_negative",
            "question_type": "negative",
            "checkpoint": 99,
            "wall_time_ms": 1764.0,
            "total_tokens": 5777,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q07_temporal",
            "question_type": "temporal",
            "checkpoint": 99,
            "wall_time_ms": 1758.5,
            "total_tokens": 5680,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q20_distractor",
            "question_type": "distractor_resistance",
            "checkpoint": 99,
            "wall_time_ms": 1686.4,
            "total_tokens": 5637,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q23_null",
            "question_type": "null_hypothesis",
            "checkpoint": 79,
            "wall_time_ms": 1677.5,
            "total_tokens": 5216,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q05_negative",
            "question_type": "negative",
            "checkpoint": 58,
            "wall_time_ms": 1358.1,
            "total_tokens": 3799,
            "tool_calls": 5
          },
          {
            "question_id": "cs03_q04_action",
            "question_type": "action_recommendation",
            "checkpoint": 119,
            "wall_time_ms": 1253.0,
            "total_tokens": 3661,
            "tool_calls": 5
          }
        ]
      }
    },
    {
      "name": "citation_coverage",
      "tier": 1,
      "value": 0.0,
      "details": {
        "num_questions": 24
      }
    },
    {
      "name": "evidence_coverage",
      "tier": 1,
      "value": 0.0,
      "details": {
        "num_questions": 24
      }
    },
    {
      "name": "evidence_grounding",
      "tier": 1,
      "value": 0.0,
      "details": {
        "total_retrieved": 0,
        "total_valid": 0
      }
    },
    {
      "name": "fact_recall",
      "tier": 1,
      "value": 0.08333333333333333,
      "details": {
        "num_questions": 24
      }
    },
    {
      "name": "insight_depth",
      "tier": 2,
      "value": 0.0,
      "details": {
        "num_questions": 24,
        "multi_episode_questions": 0
      }
    },
    {
      "name": "longitudinal_advantage",
      "tier": 3,
      "value": -0.38492063492063494,
      "details": {
        "synthesis_mean": 0.11507936507936507,
        "control_mean": 0.5,
        "synthesis_count": 21,
        "control_count": 2,
        "method": "pairwise"
      }
    },
    {
      "name": "naive_baseline_advantage",
      "tier": 3,
      "value": 0.21371527777777777,
      "details": {
        "win_rate": 0.0805,
        "loss_rate": 0.7816,
        "tie_rate": 0.1379,
        "total_fact_comparisons": 87,
        "per_type": {
          "action_recommendation": 0.6667,
          "counterfactual": 0.0,
          "distractor_resistance": 0.0,
          "evidence_sufficiency": 0.125,
          "longitudinal": 0.3583,
          "negative": 0.3333,
          "paraphrase": 0.0667,
          "severity_assessment": 0.0,
          "temporal": 0.0208
        },
        "per_question": [
          {
            "question_id": "cs03_q04_action",
            "question_type": "action_recommendation",
            "win_rate": 0.6667,
            "fact_count": 3
          },
          {
            "question_id": "cs03_q01_longitudinal",
            "question_type": "longitudinal",
            "win_rate": 0.7,
            "fact_count": 5
          },
          {
            "question_id": "cs03_q13_paraphrase",
            "question_type": "paraphrase",
            "win_rate": 0.2,
            "fact_count": 5
          },
          {
            "question_id": "cs03_q05_negative",
            "question_type": "negative",
            "win_rate": 0.0,
            "fact_count": 2
          },
          {
            "question_id": "cs03_q18_temporal",
            "question_type": "temporal",
            "win_rate": 0.0,
            "fact_count": 3
          },
          {
            "question_id": "cs03_q19_distractor",
            "question_type": "distractor_resistance",
            "win_rate": 0.0,
            "fact_count": 2
          },
          {
            "question_id": "cs03_q24_evidence",
            "question_type": "evidence_sufficiency",
            "win_rate": 0.125,
            "fact_count": 8
          },
          {
            "question_id": "cs03_q11_longitudinal",
            "question_type": "longitudinal",
            "win_rate": 0.375,
            "fact_count": 8
          },
          {
            "question_id": "cs03_q12_severity",
            "question_type": "severity_assessment",
            "win_rate": 0.0,
            "fact_count": 8
          },
          {
            "question_id": "cs03_q15_negative",
            "question_type": "negative",
            "win_rate": 0.25,
            "fact_count": 2
          },
          {
            "question_id": "cs03_q17_temporal",
            "question_type": "temporal",
            "win_rate": 0.0625,
            "fact_count": 8
          },
          {
            "question_id": "cs03_q21_distractor",
            "question_type": "distractor_resistance",
            "win_rate": 0.0,
            "fact_count": 2
          },
          {
            "question_id": "cs03_q22_counterfactual",
            "question_type": "counterfactual",
            "win_rate": 0.0,
            "fact_count": 8
          },
          {
            "question_id": "cs03_q03_longitudinal",
            "question_type": "longitudinal",
            "win_rate": 0.0,
            "fact_count": 5
          },
          {
            "question_id": "cs03_q06_paraphrase",
            "question_type": "paraphrase",
            "win_rate": 0.0,
            "fact_count": 4
          },
          {
            "question_id": "cs03_q07_temporal",
            "question_type": "temporal",
            "win_rate": 0.0,
            "fact_count": 3
          },
          {
            "question_id": "cs03_q08_counterfactual",
            "question_type": "counterfactual",
            "win_rate": 0.0,
            "fact_count": 3
          },
          {
            "question_id": "cs03_q14_paraphrase",
            "question_type": "paraphrase",
            "win_rate": 0.0,
            "fact_count": 4
          },
          {
            "question_id": "cs03_q16_negative",
            "question_type": "negative",
            "win_rate": 0.75,
            "fact_count": 2
          },
          {
            "question_id": "cs03_q20_distractor",
            "question_type": "distractor_resistance",
            "win_rate": 0.0,
            "fact_count": 2
          }
        ],
        "method": "pairwise_vs_naive"
      }
    },
    {
      "name": "reasoning_quality",
      "tier": 2,
      "value": 0.16666666666666666,
      "details": {
        "num_questions": 24,
        "qualified": 4
      }
    }
  ],
  "composite_score": 0.0
}